Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis?

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab.

Listen now to hear the findings and what this means for future clinical practice! 

You can read this article [https://doi.org/10.1093/rheumatology/kead457] in Rheumatology.

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn. 

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.